Advertisement
Screener

ALPHA TEKNOVA, INC. (TKNO) Graph

TKNO Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $12.19M; Cost of revenue $7.30M; Research and development $554.00K; Operating expenses $7.78M.
  • 2026-03-31: Revenue $11.08M; Cost of revenue $7.29M; Research and development $609.00K; Operating expenses $8.08M.
  • 2025-12-31: Revenue $9.98M*; Cost of revenue $6.74M*; Research and development $522.00K*; Operating expenses $7.85M*.
  • 2025-09-30: Revenue $10.45M; Cost of revenue $7.25M; Research and development $542.00K; Operating expenses $7.22M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

TKNO revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Clinical Solutions$2.43MLab Essentials$9.18MOther Product$573.00KRevenue$12.18MCost of revenue$7.30MGross profit$4.88MOperating expenses$7.78MOperating income-$2.89MOther income, net-$250.00KResearch & development$554.00KPre-tax income-$3.14MIncome tax$30.00KNet income-$3.17M

Geography

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

TKNO revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Non Us$526.00KUS$11.66MRevenue$12.18MCost of revenue$7.30MGross profit$4.88MOperating expenses$7.78MOperating income-$2.89MOther income, net-$250.00KResearch & development$554.00KPre-tax income-$3.14MIncome tax$30.00KNet income-$3.17M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$12.19M$7.30M$554.00K$7.78M$30.00K-$3.17M
2026-03-31$11.08M$7.29M$609.00K$8.08M$47.00K-$4.55M
2025-12-31$9.98M*$6.74M*$522.00K*$7.85M*-$62.00K*-$4.76M*
2025-09-30$10.45M$7.25M$542.00K$7.22M$79.00K-$4.29M
2025-06-30$10.29M$6.30M$581.00K$7.37M$19.00K-$3.57M
2025-03-31$9.79M$6.79M$552.00K$7.97M$22.00K-$4.64M
2024-09-30$9.58M$9.49M$627.00K$7.52M-$8.00K-$7.57M
2024-06-30$9.61M$6.81M$678.00K$7.90M-$8.00K-$5.36M
2024-03-31$9.29M$7.08M$860.00K$10.20M-$34.00K-$8.10M
2023-09-30$8.17M$6.70M$1.40M$10.23M$9.00K-$10.15M
2023-06-30$11.53M$6.46M$1.46M$12.06M$15.00K-$7.15M
2023-03-31$9.12M$6.70M$1.40M$11.37M-$18.00K-$8.82M
2022-09-30$10.69M$5.92M$1.93M$27.72M-$374.00K-$22.47M
2022-06-30$11.69M$6.44M$1.93M$11.87M-$395.00K-$6.20M
2022-03-31$11.15M$5.80M$2.01M$11.19M-$359.00K-$5.50M
2021-09-30$9.39M$5.13M$1.37M$8.15M-$892.00K-$3.25M
2021-06-30$8.31M$4.96M$851.00K$5.88M-$583.00K-$2.25M
2021-03-31$9.08M$4.05M$700.00K$5.85M-$165.00K-$655.00K
2020-09-30$8.98M$3.90M$358.00K$2.94M$636.00K$1.53M
2020-06-30$6.04M$2.58M$341.00K$2.77M$211.00K$512.00K

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$23.26M$14.59M$1.16M$15.86M$77.00K-$7.72M
2025-06-30$20.08M$13.09M$1.13M$15.34M$41.00K-$8.21M
2024-06-30$18.90M$13.89M$1.54M$18.10M-$42.00K-$13.46M
2023-06-30$20.65M$13.16M$2.86M$23.43M-$3.00K-$15.97M
2022-06-30$22.84M$12.24M$3.94M$23.07M-$754.00K-$11.70M
2021-06-30$17.39M$9.01M$1.55M$11.73M-$747.00K-$2.90M
2020-06-30$12.16M$5.06M$667.00K$5.38M$286.00K$1.46M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-09-30$30.54M$20.34M$1.68M$22.56M$120.00K-$12.50M
2024-09-30$28.48M$23.38M$2.17M$25.62M-$50.00K-$21.03M
2023-09-30$28.82M$19.86M$4.26M$33.67M$6.00K-$26.12M
2022-09-30$33.53M$18.16M$5.87M$50.79M-$1.13M-$34.17M
2021-09-30$26.78M$14.14M$2.92M$19.88M-$1.64M-$6.16M
2020-09-30$21.14M$8.95M$1.02M$8.32M$922.00K$2.99M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31$40.52M$27.08M$2.20M$30.42M$58.00K-$17.26M
2024-12-31$37.74M$30.51M$2.76M$33.38M-$88.00K-$26.75M
2023-12-31$36.68M$26.39M$5.57M$45.86M-$298.00K-$36.78M
2022-12-31$41.42M$23.94M$7.74M$67.14M-$1.92M-$47.47M
2021-12-31$36.89M$19.27M$4.31M$29.63M-$2.83M-$9.80M
2020-12-31$31.30M$13.54M$1.51M$13.09M$1.16M$3.57M

Similar stocks

Stock NameCountryMarket CapPE Ratio
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92